Olivier Ghez MD
Olivier Ghez is a consultant congenital cardiothoracic surgeon. He trained in Marseille, Harvard, Great Ormond St and Paris where he was awarded the prestigious Medaille d’Or. He was appointed as consultant in paediatric cardiothoracic surgery at theRoyal Brompton Hospital in 2008 and has subsequently become Chair of Children’s Heart Services.
He has an international reputation for excellence in the sphere of cardiac surgery in infants, children, teenagers and young adults. He operates at the Royal Brompton Hospital, the Harley St Clinic and the Centre Cardiothoracique de Monaco, as well as around the world with the Chain of Hope charity.
He is a fellow of the French College of Thoracic and Cardiovascular Surgery, the European Association for Thoracic and Cardiovascular Surgery and the Society for Cardiothoracic Surgeons in Great Britain and Ireland. He is active in the field of research being an Honorary Senior Lecturer at Imperial College, and has published more than 50 scientific papers.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus to showcase CardioCel at EACTS Annual Meeting
Ann: Admedus to showcase CardioCel at EACTS Annual Meeting, page-44
-
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$17.90 |
Change
-0.100(0.56%) |
Mkt cap ! $342.1M |
Open | High | Low | Value | Volume |
$18.00 | $18.00 | $17.75 | $11.68K | 651 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 600 | $17.75 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$17.99 | 39 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 600 | 17.750 |
1 | 26 | 17.660 |
1 | 26 | 17.650 |
1 | 150 | 17.600 |
1 | 200 | 17.560 |
Price($) | Vol. | No. |
---|---|---|
17.990 | 39 | 3 |
18.000 | 354 | 3 |
18.010 | 35 | 2 |
18.030 | 14 | 1 |
18.050 | 300 | 1 |
Last trade - 11.14am 15/07/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |